Anbio Biotechnology Stock Price

NasdaqGM:NNNN Community·US$984.0m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
7 Fair Values set on narratives written by author

Create a narrative

NNNN Share Price Performance

US$23.31

17.54 (303.99%)

US$23.31

17.54 (303.99%)

US$23.31

Fri, 14 Nov 25

Share Pricen/a

NNNN Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with poor track record.

1 Risk

1 Reward

View Full Analysis

Anbio Biotechnology Key Details

Last Reported Earnings

Dec 31, 2024

Next Reporting Earnings

n/a

: 0.054
: 71.90%
: 28.99%
: 0%

View Full Analysis

About NNNN

Founded: 2021
Employees: 27
CEO: Michael Lau
WebsiteView website: www.anbio.com

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.